Cargando…
Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas
BACKGROUND: An integrated diagnosis consisting of histology and molecular markers is the basis of the current WHO classification system of gliomas. In patients with suspected newly diagnosed or recurrent glioma, stereotactic biopsy is an alternative in cases in which microsurgical resection is deeme...
Autores principales: | Katzendobler, Sophie, Do, Anna, Weller, Jonathan, Dorostkar, Mario M., Albert, Nathalie L., Forbrig, Robert, Niyazi, Maximilian, Egensperger, Rupert, Thon, Niklas, Tonn, Joerg Christian, Quach, Stefanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005817/ https://www.ncbi.nlm.nih.gov/pubmed/35432168 http://dx.doi.org/10.3389/fneur.2022.822362 |
Ejemplares similares
-
The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine
por: Katzendobler, Sophie, et al.
Publicado: (2022) -
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
por: Weller, Jonathan, et al.
Publicado: (2022) -
PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression
por: Weller, Jonathan, et al.
Publicado: (2021) -
Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences
por: Lietke, Stefanie, et al.
Publicado: (2021) -
Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers
por: Karschnia, Philipp, et al.
Publicado: (2021)